CR10357A - Proceso para la preparacion de indazolil ureas que inhiben receptores de vanilloides del subtipo 1 (vr1) - Google Patents

Proceso para la preparacion de indazolil ureas que inhiben receptores de vanilloides del subtipo 1 (vr1)

Info

Publication number
CR10357A
CR10357A CR10357A CR10357A CR10357A CR 10357 A CR10357 A CR 10357A CR 10357 A CR10357 A CR 10357A CR 10357 A CR10357 A CR 10357A CR 10357 A CR10357 A CR 10357A
Authority
CR
Costa Rica
Prior art keywords
subtipo
indazolil
ureas
preparation
vanilloid receptors
Prior art date
Application number
CR10357A
Other languages
English (en)
Inventor
Kirill A Lukin
Hsu Margaret Chi-Ping
Brian J Kotecki
Marvin R Leanna
Dilinie P Fernando
Original Assignee
Abbott Lab
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Abbott Lab filed Critical Abbott Lab
Publication of CR10357A publication Critical patent/CR10357A/es

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D231/00—Heterocyclic compounds containing 1,2-diazole or hydrogenated 1,2-diazole rings
    • C07D231/54—Heterocyclic compounds containing 1,2-diazole or hydrogenated 1,2-diazole rings condensed with carbocyclic rings or ring systems
    • C07D231/56—Benzopyrazoles; Hydrogenated benzopyrazoles
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/33—Heterocyclic compounds
    • A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
    • A61K31/41—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having five-membered rings with two or more ring hetero atoms, at least one of which being nitrogen, e.g. tetrazole
    • A61K31/415—1,2-Diazoles
    • A61K31/416—1,2-Diazoles condensed with carbocyclic ring systems, e.g. indazole
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P13/00—Drugs for disorders of the urinary system
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P13/00—Drugs for disorders of the urinary system
    • A61P13/10—Drugs for disorders of the urinary system of the bladder
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00—Drugs for disorders of the nervous system
    • A61P25/04—Centrally acting analgesics, e.g. opioids
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P29/00—Non-central analgesic, antipyretic or antiinflammatory agents, e.g. antirheumatic agents; Non-steroidal antiinflammatory drugs [NSAID]
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P43/00—Drugs for specific purposes, not provided for in groups A61P1/00-A61P41/00
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P7/00—Drugs for disorders of the blood or the extracellular fluid
    • A61P7/12—Antidiuretics, e.g. drugs for diabetes insipidus

Landscapes

  • Health & Medical Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Veterinary Medicine (AREA)
  • Public Health (AREA)
  • General Health & Medical Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Animal Behavior & Ethology (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • General Chemical & Material Sciences (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Engineering & Computer Science (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Diabetes (AREA)
  • Urology & Nephrology (AREA)
  • Pain & Pain Management (AREA)
  • Biomedical Technology (AREA)
  • Rheumatology (AREA)
  • Neurology (AREA)
  • Neurosurgery (AREA)
  • Hematology (AREA)
  • Epidemiology (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Plural Heterocyclic Compounds (AREA)
  • Organic Low-Molecular-Weight Compounds And Preparation Thereof (AREA)
  • Low-Molecular Organic Synthesis Reactions Using Catalysts (AREA)

Abstract

Un proceso de preparar indazolilureas que son utiles como antagonistas del receptor de vainilloides de subtipo 1 (VR1).
CR10357A 2006-04-14 2008-10-08 Proceso para la preparacion de indazolil ureas que inhiben receptores de vanilloides del subtipo 1 (vr1) CR10357A (es)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
US79209906P 2006-04-14 2006-04-14

Publications (1)

Publication Number Publication Date
CR10357A true CR10357A (es) 2008-12-11

Family

ID=38610399

Family Applications (1)

Application Number Title Priority Date Filing Date
CR10357A CR10357A (es) 2006-04-14 2008-10-08 Proceso para la preparacion de indazolil ureas que inhiben receptores de vanilloides del subtipo 1 (vr1)

Country Status (20)

Country Link
US (2) US7847104B2 (es)
EP (1) EP2012779B1 (es)
JP (1) JP2009533474A (es)
KR (2) KR20110017464A (es)
CN (4) CN101466374B (es)
AU (1) AU2007238019B2 (es)
BR (1) BRPI0709963A2 (es)
CA (1) CA2647261A1 (es)
CR (1) CR10357A (es)
EC (1) ECSP088878A (es)
ES (1) ES2385404T3 (es)
MX (1) MX2008013205A (es)
MY (1) MY145334A (es)
NO (1) NO20084698L (es)
NZ (1) NZ571705A (es)
RU (1) RU2446161C2 (es)
TW (1) TW200815362A (es)
UA (1) UA94100C2 (es)
WO (1) WO2007121339A2 (es)
ZA (1) ZA200808596B (es)

Families Citing this family (6)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
WO2009055730A1 (en) * 2007-10-25 2009-04-30 Genentech, Inc. Process for making thienopyrimidine compounds
US8232411B2 (en) 2008-03-20 2012-07-31 Abbott Laboratories Methods for making central nervous system agents that are TRPV1 antagonists
CN102070420B (zh) * 2011-01-04 2013-12-18 常州大学 一种2-溴-6-氟苯甲醛的制备方法
WO2014158640A1 (en) * 2013-03-13 2014-10-02 Dow Agrosciences Llc Improved process for the preparation of certain triaryl rhamnose carbamates
AU2017295745A1 (en) 2016-07-12 2019-01-31 Bayer Cropscience Aktiengesellschaft Bicyclic compounds as pest control agents
CN106977535A (zh) * 2017-04-28 2017-07-25 大连联化化学有限公司 一种合成2‑氰基3‑氟苯硼酸工艺

Family Cites Families (16)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
GB1054833A (es) * 1963-08-09
DE2458965C3 (de) * 1974-12-13 1979-10-11 Bayer Ag, 5090 Leverkusen 3-Amino-indazol-N-carbonsäure-Derivate, Verfahren zu ihrer Herstellung sowie sie enthaltende Arzneimittel
US5905080A (en) * 1993-08-20 1999-05-18 Smithkline Beecham, P.L.C. Amide and urea derivatives as 5HT1D receptor antagonists
IL161576A0 (en) * 2001-10-26 2004-09-27 Aventis Pharma Inc Benzimidazoles and analogues and their use as protein kinases inhibitors
BR0309551A (pt) 2002-04-26 2005-02-09 Upjohn Co Derivados substituìdos de pirazina
KR100976076B1 (ko) * 2003-05-22 2010-08-17 아보트 러보러터리즈 인다졸, 벤즈이속사졸 및 벤즈이소티아졸 키나제 억제제
US7015233B2 (en) * 2003-06-12 2006-03-21 Abbott Laboratories Fused compounds that inhibit vanilloid subtype 1 (VR1) receptor
US7375126B2 (en) * 2003-06-12 2008-05-20 Abbott Laboratories Fused compounds that inhibit vanilloid receptor subtype 1 (VR1) receptor
JP4499721B2 (ja) * 2003-06-30 2010-07-07 ヒフ バイオ,インク. 化合物、組成物および方法
US20050267096A1 (en) * 2004-05-26 2005-12-01 Pfizer Inc New indazole and indolone derivatives and their use pharmaceuticals
US20070021450A1 (en) * 2004-07-16 2007-01-25 Benjamin Sklarz Indanylamino uracils and their use as antioxidants and neuroprotectants
WO2006020070A2 (en) * 2004-07-16 2006-02-23 Teva Pharmaceutical Industries, Ltd. Indanylamino uracils and their use as antioxidants and neuroprotectants
EP1940843A4 (en) * 2005-08-11 2010-09-15 Ariad Pharma Inc UNSATURATED HETEROCYCLIC DERIVATIVES
GB0520657D0 (en) * 2005-10-11 2005-11-16 Ludwig Inst Cancer Res Pharmaceutical compounds
US20070149508A1 (en) * 2005-11-02 2007-06-28 Targegen, Inc. Six membered heteroaromatic inhibitors targeting resistant kinase mutations
BRPI0619263A2 (pt) * 2005-11-30 2011-09-27 Hoffmann La Roche indóis de 3-amino-1-arilpropila e indóis aza-substituìdos, métodos para prepará-los, composição farmacêutica e uso dos referidos indóis

Also Published As

Publication number Publication date
EP2012779A4 (en) 2010-11-24
KR20090003335A (ko) 2009-01-09
US20070244178A1 (en) 2007-10-18
US7847104B2 (en) 2010-12-07
AU2007238019A1 (en) 2007-10-25
TW200815362A (en) 2008-04-01
US20110040102A1 (en) 2011-02-17
CN102140081A (zh) 2011-08-03
RU2008144961A (ru) 2010-05-20
RU2446161C2 (ru) 2012-03-27
UA94100C2 (ru) 2011-04-11
ZA200808596B (en) 2010-03-31
BRPI0709963A2 (pt) 2011-08-02
US8519186B2 (en) 2013-08-27
CN101466374B (zh) 2012-03-21
KR20110017464A (ko) 2011-02-21
JP2009533474A (ja) 2009-09-17
NZ571705A (en) 2012-03-30
CN101466374A (zh) 2009-06-24
EP2012779A2 (en) 2009-01-14
WO2007121339A2 (en) 2007-10-25
CN102321025A (zh) 2012-01-18
KR101118932B1 (ko) 2012-02-27
ES2385404T3 (es) 2012-07-24
CA2647261A1 (en) 2007-10-25
ECSP088878A (es) 2008-12-30
NO20084698L (no) 2008-11-07
MX2008013205A (es) 2008-10-22
CN102775350A (zh) 2012-11-14
WO2007121339A3 (en) 2008-10-02
MY145334A (en) 2012-01-31
HK1123725A1 (en) 2009-06-26
EP2012779B1 (en) 2012-05-16
AU2007238019B2 (en) 2013-03-14

Similar Documents

Publication Publication Date Title
ECSP088989A (es) (aza)ciclohexanos carboxilados nuevos como ligandos de receptores de dopamina d3
CR10872A (es) Compuestos agonistas y antagonistas del receptor de esfingosina-1-fosfato
CO2018004800A2 (es) Antagonistas del receptor muscarinico 4 y metodos de uso.
UY32996A (es) Antagonistas del receptor crth2 basados en indol
AR061727A1 (es) Sintesis de dietil [[ 5- ( 3-fluorofenil) -piridin -2il] metil] fosfonato
UY32225A (es) Antagonistas de cicloalcano[b]azaindol de los receptores de la prostaglandina d2
UY32327A (es) Antagonistas de receptores de ácido lisofosfatídico
ECSP088878A (es) Proceso para la preparación de indazolil ureas que inhiben receptores de vanilloides del subtipo 1 (vr1)
CO6361994A2 (es) Antagonistas del receptor de orexina de isonicotinamida
EA201501122A1 (ru) Новые агонисты соматостатиновых рецепторов подтипа 4 (sstr4)
UY31124A1 (es) Derivados de oxiadazol y su uso como potenciadores del receptor metabotropico de glutamato - 842
UY34530A (es) Antagonistas del receptor de vanilloides de potencial transitorio 1 (trpv1)
HN2008000646A (es) Antagonistas de los receptores 2 de dopamina de rapida disociacion
UA107360C2 (en) Bicyclic aryl sphingosine 1-phosphate analogs
ECSP11011439A (es) Compuestos 1-cianoetilheterociclilcarboxamida sustituidos 750
CL2007003826A1 (es) Compuestos derivados de n-(amino-(hetero)aril)-1h-pirrolopiridin-2-carboxamidas, antagonistas de receptores tipo trpv1; procedimiento de preparacion; composicion farmaceutica; y uso para el tratamiento de enfermedades tales como trastornos gastrointestinales, trastornos respiratorios, psoriasis y depresion.
CO6410295A2 (es) Derivados de indol como antagonistas del receptor crth2
CO6290752A2 (es) Antagonistas n,n-disustituidos de aminoalquilbifenilo de receptores d2 de prostaglandina
ECSP078018A (es) Agonistas del receptor de niacina, composiciones que contienen tales compuestos y procedimientos para tratamiento
EA201000316A1 (ru) Производные изохинолинила и изоиндолинила в качестве антагонистов гистаминовых рецепторов 3 подтипа
CO6470826A2 (es) Moduladores de lxr
CO6351723A2 (es) Derivados de pirazolo-[5,1-b]-oxazol como antagonistas de crf1
ECSP099692A (es) Ligandos de receptor de vainilloide novedosos y su uso de los mismos para la produccion de sustancias farmaceuticas
CL2009000532A1 (es) Compuestos derivados de piridin-2-ilo; agonista del receptor s1p1/edg1; composición farmacéutica que los comprende; uso en trastornos asociados con el sitema inmunitario.
ECSP099046A (es) Derivados ciclopropil amina

Legal Events

Date Code Title Description
FA Abandonment or withdrawal (granting procedure)